Bilaketaren emaitzak - Andreas Türler

Alpha-PET with terbium-149: evidence and perspectives for radiotheragnostics nork Cristina Müller, Christiaan Vermeulen, Ulli Köster, Karl Johnston, Andreas Türler, Roger Schibli, Nicholas P. van der Meulen

Connect to this object online.

Folate Receptor Targeted Alpha-Therapy Using Terbium-149 nork Cristina Müller, Josefine Reber, Stephanie Haller, Holger Dorrer, Ulli Köster, Karl Johnston, Konstantin Zhernosekov, Andreas Türler, Roger Schibli

Connect to this object online.

44Sc for labeling of DOTA- and NODAGA-functionalized peptides: preclinical in vitro and in vivo investigations nork Katharina A. Domnanich, Cristina Müller, Renata Farkas, Raffaella M. Schmid, Bernard Ponsard, Roger Schibli, Andreas Türler, Nicholas P. van der Meulen

Connect to this object online.

47Sc as useful β--emitter for the radiotheragnostic paradigm: a comparative study of feasible production routes nork Katharina A. Domnanich, Cristina Müller, Martina Benešová, Rugard Dressler, Stephanie Haller, Ulli Köster, Bernard Ponsard, Roger Schibli, Andreas Türler, Nicholas P. van der Meulen

Connect to this object online.

Production and separation of 43Sc for radiopharmaceutical purposes nork Katharina A. Domnanich, Robert Eichler, Cristina Müller, Sara Jordi, Vera Yakusheva, Saverio Braccini, Martin Behe, Roger Schibli, Andreas Türler, Nicholas P. van der Meulen

Connect to this object online.

Evaluation of Radiolabeled Girentuximab In Vitro and In Vivo nork Tais Basaco, Stefanie Pektor, Josue M. Bermudez, Niurka Meneses, Manfred Heller, José A. Galván, Kayluz F. Boligán, Stefan Schürch, Stephan von Gunten, Andreas Türler, Matthias Miederer

Connect to this object online.